세계의 유아용 조제분유 및 제품 시장 규모, 점유율, 성장, 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2024-2032년)

Growth Factors of infant formula ingredients and products Market

The global infant formula ingredients and products market continues to grow steadily, driven by increasing awareness of infant nutrition, rising female workforce participation, and technological advancements in formula composition. According to Fortune Business Insights, the market was valued at USD 74.94 billion in 2024, is projected to reach USD 77.64 billion in 2025, and is estimated to expand to USD 109.70 billion by 2032, reflecting a CAGR of 5.06% during the forecast period (2025-2032). Asia Pacific dominated the global landscape in 2024, accounting for 66.2% of the market share, with a valuation of USD 49.61 billion, underscoring the region's strong consumer base and growing focus on infant health and wellness.

Infant formula products are designed to serve as alternatives to breast milk, providing balanced nutrition through key ingredients such as proteins, carbohydrates, fats, vitamins, and minerals. These formulas are often derived from cow's milk but can also be sourced from soy, goat milk, and other plant-based materials. The market is being driven by global players like Nestle S.A., Abbott, Danone S.A., and Reckitt Benckiser Group plc, who continue to introduce advanced products catering to infants with diverse dietary and medical needs.

Market Dynamics

Market Drivers - Growing Parental Awareness and Demand for Specialized Formulas

Rising parental awareness about the importance of infant nutrition has significantly fueled the demand for scientifically formulated products that closely resemble human milk. Increasingly health-conscious parents in Asia, the Middle East, and North America are seeking formulas enriched with HMOs (Human Milk Oligosaccharides), prebiotics, and Lactoferrin, which support immunity and digestive health.

The demand for specialty infant formulas is another key growth driver. As the prevalence of lactose intolerance and food allergies among infants rises, manufacturers are launching innovative lactose-free, hypoallergenic, and plant-based products. For instance, in September 2024, Perrigo Company plc partnered with Dr. Brown's Company and Good Start to introduce a 100% plant-based, lactose-free infant formula available through major U.S. retailers such as Walmart, Kroger, and Amazon. These specialized solutions help infants with allergies or sensitivities, supporting market expansion worldwide.

Market Restraints - High Production Costs and Ingredient Price Volatility

Despite strong demand, the high manufacturing costs of infant formula ingredients-driven by the procurement of high-quality milk powder, vegetable oils, and vitamins-pose a significant challenge. Price fluctuations in raw materials, especially organic and specialty components, combined with supply chain disruptions and energy cost increases, have impacted production margins.

Market Opportunities - Technological Innovations in Formula Development

Technological advancements have opened new avenues for market expansion. Cutting-edge production techniques such as microfiltration, supercritical fluid extraction, and fermentation-based synthesis are enabling the creation of ingredients that mimic human milk properties more closely than ever before. For example, in April 2020, Conagen Inc. developed Lactoferrin-a key protein for infant immunity-using fermentation technology, reducing dependence on traditional dairy sources and lowering production costs.

Market Trends

Emerging Preference for Human-Milk-Mimicking Ingredients

Consumers increasingly favor infant formulas enriched with components that replicate the nutritional structure of human milk. Ingredients such as OPO (Structured Lipids), HMOs, and A2 B-casein proteins are gaining traction, particularly in China, India, and Southeast Asia. In October 2023, International Flavors & Fragrances (IFF), DSM-Firmenich, and Mengniu received regulatory approval to use HMOs and probiotics in infant formula production in China, signaling a shift toward premium, biologically advanced formulations.

Segmentation Insights

By Ingredient Type:

In 2024, carbohydrates held the largest share of the global infant formula ingredients market, as they serve as the primary energy source for infants. Lactose supports brain development and nutrient absorption, making it an essential component in most formulas. Fats accounted for the second-largest share, contributing 40-45% of infants' caloric intake and promoting nervous system development. Proteins, crucial for tissue growth and repair, held the third-largest share. The prebiotics and probiotics segment is projected to grow the fastest through 2032, supported by ongoing innovations targeting gut and immune health.

By Product Type:

The specialty formula segment dominated the market in 2024, addressing specific dietary needs such as allergies, metabolic disorders, and premature birth nutrition. The HMO-enriched formula segment represents the fastest-growing category, driven by its similarity to natural breast milk composition and its ability to enhance infants' immune and digestive systems. In March 2023, Danone launched Pepticate, a hypoallergenic hydrolyzed powdered formula in the U.S., to cater to infants with cow's milk allergies.

Regional Outlook

Asia Pacific - The Leading Market in 2024

Asia Pacific held the dominant share with a market value of USD 49.61 billion in 2024, driven by increasing female workforce participation, rapid urbanization, and expanding middle-class populations. Countries such as China, India, and Indonesia are witnessing a strong demand for premium and specialized infant nutrition products. The Chinese government's two-child policy reform has also stimulated birth rates, leading to higher product consumption. According to the World Bank, increasing women's workforce participation could enhance the region's GDP by 51%, indirectly boosting the infant formula market.

North America:

Following the 2022 infant formula shortage in the U.S., manufacturers are strengthening local supply chains and safety regulations to ensure product stability. Domestic production and government intervention continue to shape the region's recovery and supply consistency.

Europe:

European consumers show a strong inclination toward organic and additive-free formulas, with growing adoption of HMO- and A2-protein-based products. Premium offerings targeting lactose intolerance and allergy management are driving steady regional growth.

South America:

The region's stable birth rates and rising disposable incomes are fueling demand for functional, plant-based soy formulas. Manufacturers in Brazil and Argentina are focusing on positioning their products with claims such as "supports bone health" and "gentle on the stomach" to attract health-conscious parents.

Middle East & Africa:

The increasing expatriate population and demand for premium imported infant formulas are contributing to market expansion, especially in the United Arab Emirates and Saudi Arabia.

Competitive Landscape

The market features strong competition among leading companies such as Nestle S.A. (Switzerland), Abbott (U.S.), Danone S.A. (France), Reckitt Benckiser Group plc (U.K.), and Junlebao Dairy Group (China). Other notable players include Fonterra Co-operative Group Limited, DSM-Firmenich, Cargill, Inc., Almarai, and FrieslandCampina N.V.

Recent Industry Developments:

• May 2025: Arla Food Ingredients partnered with Brenntag Group to expand its protein ingredient distribution across Southeast Asia.
• December 2024: Novonesis launched 2'-FL human milk oligosaccharides for use in infant formula across the Chinese market.
• October 2023: ARLA FOODS AMBA invested in Argentina to expand its infant nutrition capabilities.
• November 2022: FrieslandCampina introduced new fish-oil-free DHA and ARA infant formula ingredients.

Conclusion

The global infant formula ingredients and products market is set to expand from USD 74.94 billion in 2024 to USD 109.70 billion by 2032, reflecting sustained growth across all regions. Rising consumer awareness, technological innovation, and premiumization trends are reshaping the infant nutrition industry. With Asia Pacific leading the charge and Western markets focusing on safety, sustainability, and advanced formulations, the sector is poised to achieve strong, innovation-driven growth throughout the 2025-2032 period.

Segmentation By Ingredient Type

• Carbohydrates
• Fats
• Proteins
• Prebiotics and Probiotics
• Vitamins and Minerals
• Others

By Product Type

• Organic Formulas
• Goat milk-based Formulas
• OPO-enriched Product
• Soy-Based Formula
• Specialty Formula
• HMO-Enriched Formula
• A2 Protein Formula
• Lactoferrin-Enriched Formula
• Others

By Region

• North America (By Ingredient Type, Product Type, and Country)
  • U.S.
  • Canada
  • Mexico
• Europe (By Ingredient Type, Product Type, and Country)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia (By Ingredient Type, Product Type, and Country)
  • China
  • India
  • Japan
  • South Korea
  • Southeast Asia
  • Rest of Asia
• South America (By Ingredient Type, Product Type, and Country)
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa (By Ingredient Type, Product Type, and Country)
  • Saudi Arabia
  • UAE
  • Qatar
  • Iran
  • Bahrain
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview of the Parent/Related Markets
• 4.2. Industry SWOT Analysis
• 4.3. Supply Chain and Regolatory Analysis
• 4.4. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
• 4.5. Impact of Tariffs on the Market

5. Global Infant Formula Ingredients and Products Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Ingredient Type
    • 5.2.1.1. Carbohydrates
    • 5.2.1.2. Fats
    • 5.2.1.3. Proteins
    • 5.2.1.4. Prebiotics and Probiotics
    • 5.2.1.5. Vitamins and Minerals
    • 5.2.1.6. Others
  • 5.2.2. By Product Type
    • 5.2.2.1. Organic Formulas
    • 5.2.2.2. Goat milk-based Formulas
    • 5.2.2.3. OPO-enriched Product
    • 5.2.2.4. Soy-Based Formula
    • 5.2.2.5. Specialty Formula
    • 5.2.2.6. HMO-Enriched Formula
    • 5.2.2.7. A2 Protein Formula
    • 5.2.2.8. Lactoferrin-Enriched Formula
    • 5.2.2.9. Others
  • 5.2.3. By Region
    • 5.2.3.1. North America
    • 5.2.3.2. Europe
    • 5.2.3.3. Asia
    • 5.2.3.4. South America
    • 5.2.3.5. Middle East & Africa

6. North America Infant Formula Ingredients and Products Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Ingredient Type
    • 6.2.1.1. Carbohydrates
    • 6.2.1.2. Fats
    • 6.2.1.3. Proteins
    • 6.2.1.4. Prebiotics and Probiotics
    • 6.2.1.5. Vitamins and Minerals
    • 6.2.1.6. Others
  • 6.2.2. By Product Type
    • 6.2.2.1. Organic Formulas
    • 6.2.2.2. Goat milk-based Formulas
    • 6.2.2.3. OPO-enriched Product
    • 6.2.2.4. Soy-Based Formula
    • 6.2.2.5. Specialty Formula
    • 6.2.2.6. HMO-Enriched Formula
    • 6.2.2.7. A2 Protein Formula
    • 6.2.2.8. Lactoferrin-Enriched Formula
    • 6.2.2.9. Others
  • 6.2.3. By Country
    • 6.2.3.1. U.S.
    • 6.2.3.2. Canada
    • 6.2.3.3. Mexico

7. Europe Infant Formula Ingredients and Products Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Ingredient Type
    • 7.2.1.1. Carbohydrates
    • 7.2.1.2. Fats
    • 7.2.1.3. Proteins
    • 7.2.1.4. Prebiotics and Probiotics
    • 7.2.1.5. Vitamins and Minerals
    • 7.2.1.6. Others
  • 7.2.2. By Product Type
    • 7.2.2.1. Organic Formulas
    • 7.2.2.2. Goat milk-based Formulas
    • 7.2.2.3. OPO-enriched Product
    • 7.2.2.4. Soy-Based Formula
    • 7.2.2.5. Specialty Formula
    • 7.2.2.6. HMO-Enriched Formula
    • 7.2.2.7. A2 Protein Formula
    • 7.2.2.8. Lactoferrin-Enriched Formula
    • 7.2.2.9. Others
  • 7.2.3. By Country
    • 7.2.3.1. Germany
    • 7.2.3.2. K.
    • 7.2.3.3. France
    • 7.2.3.4. Italy
    • 7.2.3.5. Spain
    • 7.2.3.6. Rest of Europe

8. Asia Infant Formula Ingredients and Products Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Key Findings / Summary
• 8.2. Market Size Estimates and Forecast
  • 8.2.1. By Ingredient Type
    • 8.2.1.1. Carbohydrates
    • 8.2.1.2. Fats
    • 8.2.1.3. Proteins
    • 8.2.1.4. Prebiotics and Probiotics
    • 8.2.1.5. Vitamins and Minerals
    • 8.2.1.6. Others
  • 8.2.2. By Product Type
    • 8.2.2.1. Organic Formulas
    • 8.2.2.2. Goat milk-based Formulas
    • 8.2.2.3. OPO-enriched Product
    • 8.2.2.4. Soy-Based Formula
    • 8.2.2.5. Specialty Formula
    • 8.2.2.6. HMO-Enriched Formula
    • 8.2.2.7. A2 Protein Formula
    • 8.2.2.8. Lactoferrin-Enriched Formula
    • 8.2.2.9. Others
  • 8.2.3. By Country
    • 8.2.3.1. China
    • 8.2.3.2. India
    • 8.2.3.3. Japan
    • 8.2.3.4. South Korea
    • 8.2.3.5. Southeast Asia
    • 8.2.3.6. Rest of Asia

9. South America Infant Formula Ingredients and Products Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Key Findings / Summary
• 9.2. Market Size Estimates and Forecast
  • 9.2.1. By Ingredient Type
    • 9.2.1.1. Carbohydrates
    • 9.2.1.2. Fats
    • 9.2.1.3. Proteins
    • 9.2.1.4. Prebiotics and Probiotics
    • 9.2.1.5. Vitamins and Minerals
    • 9.2.1.6. Others
  • 9.2.2. By Product Type
    • 9.2.2.1. Organic Formulas
    • 9.2.2.2. Goat milk-based Formulas
    • 9.2.2.3. OPO-enriched Product
    • 9.2.2.4. Soy-Based Formula
    • 9.2.2.5. Specialty Formula
    • 9.2.2.6. HMO-Enriched Formula
    • 9.2.2.7. A2 Protein Formula
    • 9.2.2.8. Lactoferrin-Enriched Formula
    • 9.2.2.9. Others
  • 9.2.3. By Country
    • 9.2.3.1. Brazil
    • 9.2.3.2. Argentina
    • 9.2.3.3. Rest of South America

10. Middle East & Africa Infant Formula Ingredients and Products Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Key Findings / Summary
• 10.2. Market Size Estimates and Forecast
  • 10.2.1. By Ingredient Type
    • 10.2.1.1. Carbohydrates
    • 10.2.1.2. Fats
    • 10.2.1.3. Proteins
    • 10.2.1.4. Prebiotics and Probiotics
    • 10.2.1.5. Vitamins and Minerals
    • 10.2.1.6. Others
  • 10.2.2. By Product Type
    • 10.2.2.1. Organic Formulas
    • 10.2.2.2. Goat milk-based Formulas
    • 10.2.2.3. OPO-enriched Product
    • 10.2.2.4. Soy-Based Formula
    • 10.2.2.5. Specialty Formula
    • 10.2.2.6. HMO-Enriched Formula
    • 10.2.2.7. A2 Protein Formula
    • 10.2.2.8. Lactoferrin-Enriched Formula
    • 10.2.2.9. Others
  • 10.2.3. By Country
    • 10.2.3.1. Saudi Arabia
    • 10.2.3.2. UAE
    • 10.2.3.3. Qatar
    • 10.2.3.4. Iran
    • 10.2.3.5. Bahrain
    • 10.2.3.6. Rest of the Middle East & Africa

11. Competitive Analysis

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Infant Formula Ingredients and Products Market Revenue Share/Ranking Analysis, By Key Manufacturer

12. Company Profiles

• 12.1. ARLA FOODS AMBA
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Product Portfolio
  • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.5. Recent Developments

13. Similar information has been provided for all the below companies

• 13.1. Fonterra Co-operative Group Limited
• 13.2. Abbott
• 13.3. Nestle S.A.
• 13.4. Ingredion Incorporated
• 13.5. DSM-Firmenich
• 13.6. Almarai Company
• 13.7. Cargill, Incorporated
• 13.8. Danone S.A.
• 13.9. Novonesis
• 13.10. AAK
• 13.11. Friesland Campina
• 13.12. Reckitt Benckiser Group plc
• 13.13. Junlebao Dairy Group
• 13.14. Hero Group